CJ Bioscience
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
311690 | KO
Overview
Corporate Details
- ISIN(s):
- KR7311690002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 세종대로 14 그랜드센트럴타워 B동 7층, 중구
- Website:
- https://www.cjbioscience.com/en/
Description
CJ Bioscience is a company focused on developing microbiome-based therapeutics to address unmet medical needs. It utilizes a proprietary AI-powered drug discovery platform, Ez-Mx®, to identify and advance novel live biotherapeutic products (LBPs). The company's primary focus is on creating treatments for complex diseases, with a pipeline targeting oncology and inflammatory bowel disease (IBD). Key candidates include CJRB-101, its lead oncology asset, and CJRB-201, a promising oral therapeutic for IBD that has demonstrated significant anti-inflammatory efficacy in preclinical models. In addition to its drug development programs, CJ Bioscience provides next-generation sequencing (NGS) and bioinformatics solutions to the global research community through its EzBioCloud platform.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-28 00:00 |
정기주주총회결과
|
Korean | 18.4 KB | ||
| 2023-03-27 00:00 |
투자판단관련주요경영사항(마이크로바이옴 치료제 연구개발을 위한 기술도입 계약 체결)
|
Korean | 10.0 KB | ||
| 2023-03-20 00:00 |
감사보고서제출
|
Korean | 25.5 KB | ||
| 2023-03-20 00:00 |
사업보고서 (2022.12)
|
Korean | 1.7 MB | ||
| 2023-03-10 00:00 |
주주총회소집공고
|
Korean | 173.9 KB | ||
| 2023-02-28 00:00 |
주주총회소집결의
|
Korean | 7.4 KB | ||
| 2023-02-27 00:00 |
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 9.1 KB | ||
| 2023-02-01 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.0 KB | ||
| 2023-01-20 00:00 |
투자판단관련주요경영사항(마이크로바이옴 면역항암치료제 CJRB-101의 미국 FDA 제1/2상 임상시험계획(IND) 승인)
|
Korean | 13.8 KB | ||
| 2022-12-26 00:00 |
투자판단관련주요경영사항(마이크로바이옴 면역항암치료제 CJRB-101의 미국 FDA 제1/2상 임상시험계획(IND) 신청)
|
Korean | 9.4 KB | ||
| 2022-12-08 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2022-12-08 00:00 |
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
|
Korean | 5.8 KB | ||
| 2022-11-29 00:00 |
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 6.1 KB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 1.6 MB | ||
| 2022-09-01 00:00 |
투자판단관련주요경영사항(마이크로바이옴 공동연구 계약 체결)
|
Korean | 9.0 KB |
Automate Your Workflow. Get a real-time feed of all CJ Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CJ Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CJ Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
